Showing results (521-530 of 753) with videos related to
Sort By:
Pageof 76
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type GlioblastomasMaite Verreault, Charlotte Schmitt, Lauriane Goldwirt, et al.Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.Journal of Neuro-Oncology|November 18, 2016
Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastomaJayashree Kalpathy-Cramer, Vyshak Chandra, Xiao Da, et al.Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2012
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumorsIan Krop, Tim Demuth, Tina Guthrie, et al.Neuro-Oncology Advances|August 11, 2021
Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastomaBenjamin M Ellingson, Kunal Patel, Chencai Wang, et al.Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.Research Square|May 3, 2024
A first comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomasMyron K Gibert, Ying Zhang, Shekhar Saha, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade GliomaEudocia Q Lee, Dan G Duda, Alona Muzikansky, et al.Pageof 76